A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

NCT05988034 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Electrocardiography

Interventions

DRUG: Avacopan
DRUG: Moxifloxacin
DRUG: Placebo for avacopan
DRUG: Placebo for moxifloxacin

Sponsor

Amgen